← Evidence map

ReviewLeukemia2007

Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?

T SzczepańskiPubMed ↗Publisher ↗

No numbers read from the abstract.

40 papers cite it

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

NCT0242851720 enrolled2015
Full record →Abstract, authors, funding and every citing paper · PMID 17301806